4.6 (664) · $ 15.50 · In stock
PDF) The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
Patients' and health care providers' perspectives on quality of
Saunya Dover's research works SickKids, Toronto and other places
Updating the Canadian Hemophilia Outcomes–Kids' Life Assessment Tool (CHO‐ KLAT) in the era of extended half‐life clotting factor concentrates - Price - 2021 - Research and Practice in Thrombosis and Haemostasis - Wiley
PDF) Guidelines for the management of hemophilia Kathy Mulder, J. Mahlangu, and Nigel Key
Hemophilia treatment options
Hemophilia Steps for Living
Thrombin generation and implications for hemophilia therapies: A narrative review - Research and Practice in Thrombosis and Haemostasis
Updating the Canadian hemophilia outcomes-kids life assessment tool (CHO- KLAT Version2.0).